Ernexa Therapeutics unveils investor presentation update
Ernexa Therapeutics Inc. has released a new investor presentation, highlighting its strategic direction and ongoing commitment to transparency.
ChronoScale Holdings reports Q1 financial results for 2026
ChronoScale Holdings Corp announces its financial results for Q1 2026, showcasing growth in the general industrial machinery sector.
SideChannel, Inc. Amends Articles of Incorporation
SideChannel, Inc. has amended its Articles of Incorporation, reducing the number of authorized shares of common and preferred stock.
Curaleaf extends offer to acquire Aurora Cannabis shares
Curaleaf Holdings has amended its acquisition offer for Aurora Cannabis, increasing cash and share consideration while extending the deadline.
Hines Global Income Trust Expands Portfolio with $500M Acquisitions
Hines Global Income Trust expands its portfolio with over $500 million in acquisitions across Atlanta, Dallas, and Columbus, enhancing its market presence.
Constellation Brands reports Q2 results, acquires SpikedAde
Constellation Brands announces Q2 results and acquisition of SpikedAde, alongside a quarterly cash dividend declaration.
Professional Diversity Network Enters Major Agreements to Expand GPU Business
Professional Diversity Network, Inc. secures agreements worth $1.177 million to enhance its GPU infrastructure business, signaling growth in the tech sector.
BioLife Solutions completes merger with Repligen Corporation
BioLife Solutions has merged with Repligen Corporation, resulting in its delisting from Nasdaq and a shift in the electromedical industry landscape.
RTB Digital appoints Erin Schaefer to board of directors
RTB Digital, Inc. has appointed Erin Schaefer as a director, bringing extensive tech leadership experience to the management consulting firm.
60 Degrees Pharmaceuticals updates investor presentation, data
60 Degrees Pharmaceuticals updates its investor presentation and announces new data on its babesiosis treatment, signaling ongoing commitment to transparency.
iBio reveals promising data for obesity treatment IBIO-610
iBio, Inc. shares preclinical data for IBIO-610, an obesity treatment that may enhance fat loss while preserving muscle, with human trials planned for 2027.
Acura Pharmaceuticals secures $200K loan amid financial strain
Acura Pharmaceuticals obtains a $200,000 loan from Abuse Deterrent Pharma, raising total debt to over $11 million, crucial for operations.
MAIA Biotechnology Releases Presentation on Operations
MAIA Biotechnology has shared a new presentation and summary detailing its operations and performance, aiming to enhance transparency for investors.
Range Impact Announces Major Stock Issuance Agreements
Range Impact, Inc. enters significant agreements involving $1 million stock issuance, marking a strategic shift in its operations.
Tenable Holdings Appoints Charlie Bell to Board of Directors
Tenable Holdings, Inc. appoints Charlie Bell to its Board of Directors, enhancing its focus on AI-powered cybersecurity solutions.
Diodes Announces Q3 2026 Results Conference Call Date
Diodes Incorporated will host a conference call on November 5, 2026, to discuss its Q3 2026 financial results, emphasizing transparency and investor communication.
Boxlight Corp announces new preferred stock agreements
Boxlight Corp reveals new Series E Preferred Stock issuance and amendments to existing agreements, enhancing its capital structure and growth potential.
Jasper Therapeutics stockholders approve key proposals
Jasper Therapeutics' stockholders approved major proposals at a recent meeting, impacting the company's stock structure and future operations.
AITX Secures Third ROAMEO Order from Global Logistics Client
Artificial Intelligence Technology Solutions Inc. announces a major order for its ROAMEO autonomous security vehicle, enhancing its market position.
Neighborhood Intelligence Terminates Merger with Fathom Holdings
Neighborhood Intelligence, Inc. has terminated its merger with Fathom Holdings, focusing on organic growth and strong revenue momentum.